{"cursor":"6009","size":15,"audio":[],"currentlang":"en","article":"A 'Cholecystokinin antagonist' is a specific type of receptor antagonist which\nblocks the receptor sites for the peptide hormone Cholecystokinin (CCK).\n\nThere are two subtypes of this receptor known at present, defined as\nCCK A and CCK B (also called CCK-1 and CCK-2).\nCCK A is mainly expressed in the small intestine, and is involved in\nthe regulation of enzyme secretion by the pancreas, secretion of gastric acid\nin the stomach, intestinal motility and signalling of satiety (fullness).\nCCK B is expressed mainly in the central nervous system, and has\nfunctions relating to anxiety and the perception of pain.\nAntagonists for the CCK receptors can thus have multiple functions in both the\ngut and brain.\n\nThe best known CCK antagonist is the non-selective antagonist proglumide, which\nblocks both CCK A and CCK B, and was originally developed\nfor the treatment of stomach ulcers. This action derived from its blockade of\nCCK A in the gut and consequent reduction in secretion of gastric\nacid, however an interesting side effect of proglumide was found, namely that it\nincreases the analgesic effects of opioid painkillers, and decreases the\ndevelopment of tolerance. This was subsequently found to result from its\nblockade of CCK B receptors in the brain.\n\nNewer drugs have since been developed which are selective for one or other of\nthe CCK receptors. Selective CCK A antagonists such as lorglumide and\ndevazepide have been developed both for their anti-ulcer effects and as\npotential drugs to limit the development of gastrointestinal cancers such as\ncolon cancer.\n\nHowever by far the main focus of CCK antagonist research has focused on the\ndevelopment of selective CCK B antagonists as novel medications which\nhave been primarily investigated for the treatment of anxiety and panic attacks,\nas well as for other roles such as analgesic effects. The first selective\nCCK B antagonists were modified peptide molecules such as CI-988 and\nthe more metabolically stable CI-1015, however these were disadvantaged by only\nbeing able to be administered by injection and rapid breakdown inside the body,\nwhich led to a short half-life and limited utility. Non-peptide CCK B\nantagonists such as L-365,260, L-369,293, YF-476, RP-69758, LY-288,513, PD-\n145,942 and the CCK B inverse agonist L-740,093 have since been\ndeveloped, and while all of the drugs developed so far have suffered\nfrom limited bioavailability or other issues which have hindered their clinical\ndevelopment, research in this area continues.\n\nCCK A receptors are also expressed in the brain to some extent, and\ninterestingly IQM-95333, an antagonist selective for this population of\nCCK A receptors, was also found to reduce anxiety in animal\nmodels. Conversely, inhibition of CCK B receptors in the\ngut produces similar inhibition of secretion of gastric acid and pepsinogen\nenzymes as is seen with inhibition of CCK A receptors,\nsuggesting that while the CCK A and CCK B receptors comprise\ntwo structurally distinct families which bind different ligands and are\nprimarily expressed in different tissues, they produce similar effects, and the\ndistinction between their gastrointestinal and anxiolytic actions depends mainly\non where they are expressed in the body.\n","linknr":149,"url":"Cholecystokinin_antagonist","recorded":1375692117,"links":["/w/index.php?title=Cholecystokinin_antagonist&action=edit","/w/index.php?title=Cholecystokinin_antagonist&action=edit","//bits.wikimedia.org/favicon/wikipedia.ico","/w/opensearch_desc.php","//en.wikipedia.org/w/api.php?action=rsd","//creativecommons.org/licenses/by-sa/3.0/","/w/index.php?title=Special:RecentChanges&feed=atom","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=ext.gadget.DRN-wizard%2CReferenceTooltips%2Ccharinsert%2Cteahouse%7Cext.rtlcite%2Cwikihiero%7Cext.uls.nojs%7Cmediawiki.legacy.commonPrint%2Cshared%7Cmw.PopUpMediaTransform%7Cskins.vector&only=styles&skin=vector&*","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=site&only=styles&skin=vector&*","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=startup&only=scripts&skin=vector&*","//bits.wikimedia.org/geoiplookup","//meta.wikimedia.org","#mw-navigation","#p-search","/wiki/Receptor_antagonist","/wiki/Peptide","/wiki/Hormone","/wiki/Cholecystokinin","/wiki/Cholecystokinin_receptor","/wiki/Cholecystokinin_A_receptor","/wiki/Cholecystokinin_B_receptor","#cite_note-1","/wiki/Proglumide","/wiki/Lorglumide","/wiki/Devazepide","#cite_note-2","/wiki/CI-988","#cite_note-3","#cite_note-4","#cite_note-5","#cite_note-6","/w/index.php?title=Cholecystokinin_antagonist&action=edit&section=1","#cite_ref-1","/wiki/Digital_object_identifier","http://dx.doi.org/10.1016%2Fj.beem.2004.07.002","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/15533776","#cite_ref-2","/wiki/Digital_object_identifier","http://dx.doi.org/10.1111%2Fj.1600-079X.2005.00239.x","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/16150104","#cite_ref-3","/wiki/Digital_object_identifier","http://dx.doi.org/10.1016%2FS0301-0082%2898%2900090-2","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/10368033","#cite_ref-4","/wiki/Digital_object_identifier","http://dx.doi.org/10.2174%2F156802607780960500","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/17584141","#cite_ref-5","http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1564744","/wiki/British_Journal_of_Pharmacology","/wiki/Digital_object_identifier","http://dx.doi.org/10.1038%2Fsj.bjp.0701186","/wiki/PubMed_Central","//www.ncbi.nlm.nih.gov/pmc/articles/PMC1564744","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/9208145","/wiki/Help:CS1_errors#displayauthors","#cite_ref-6","/wiki/Digital_object_identifier","http://dx.doi.org/10.1016%2FS0014-2999%2899%2900212-5","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/10408253","/wiki/Template:Hormone_antagonists","/wiki/Template_talk:Hormone_antagonists","//en.wikipedia.org/w/index.php?title=Template:Hormone_antagonists&action=edit","/wiki/Receptor_antagonist","/wiki/Hormone_antagonist","/wiki/Hypothalamus","/wiki/Pituitary_gland","/wiki/Hypothalamic%E2%80%93pituitary%E2%80%93adrenal_axis","/wiki/Corticotropin_releasing_hormone_antagonist","/wiki/Antiglucocorticoid","/wiki/Antimineralocorticoid","/wiki/Selective_glucocorticoid_receptor_modulator","/wiki/Hypothalamic-pituitary-thyroid_axis","/wiki/Antithyroid_agent","/wiki/Hypothalamic-pituitary-gonadal_axis","/wiki/Antiandrogen","/wiki/Antigonadotropin","/wiki/Antiestrogen","/wiki/Gonadotropin-releasing_hormone_antagonist","/wiki/Antiprogestogen","/wiki/Selective_androgen_receptor_modulator","/wiki/Selective_estrogen_receptor_modulator","/wiki/Selective_progesterone_receptor_modulator","/wiki/Eicosanoid","/wiki/Leukotriene_antagonist","/wiki/Prostaglandin_antagonist","//en.wikipedia.org/w/index.php?title=Special:CentralAutoLogin/start&type=1x1&from=enwiki","http://en.wikipedia.org/w/index.php?title=Cholecystokinin_antagonist&oldid=545269729","/wiki/Help:Categories","/wiki/Category:Cholecystokinin_antagonists","/wiki/Category:Pages_using_citations_with_old-style_implicit_et_al.","/w/index.php?title=Special:UserLogin&returnto=Cholecystokinin+antagonist&type=signup","/w/index.php?title=Special:UserLogin&returnto=Cholecystokinin+antagonist","/wiki/Cholecystokinin_antagonist","/w/index.php?title=Talk:Cholecystokinin_antagonist&action=edit&redlink=1","#","/wiki/Cholecystokinin_antagonist","/w/index.php?title=Cholecystokinin_antagonist&action=edit","/w/index.php?title=Cholecystokinin_antagonist&action=history","#","/w/index.php","//bits.wikimedia.org/static-1.22wmf11/skins/vector/images/search-ltr.png?303-4","/wiki/Main_Page","/wiki/Main_Page","/wiki/Portal:Contents","/wiki/Portal:Featured_content","/wiki/Portal:Current_events","/wiki/Special:Random","//donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&utm_medium=sidebar&utm_campaign=C13_en.wikipedia.org&uselang=en","/wiki/Help:Contents","/wiki/Wikipedia:About","/wiki/Wikipedia:Community_portal","/wiki/Special:RecentChanges","//en.wikipedia.org/wiki/Wikipedia:Contact_us","/wiki/Special:WhatLinksHere/Cholecystokinin_antagonist","/wiki/Special:RecentChangesLinked/Cholecystokinin_antagonist","/wiki/Wikipedia:File_Upload_Wizard","/wiki/Special:SpecialPages","/w/index.php?title=Cholecystokinin_antagonist&oldid=545269729","/w/index.php?title=Cholecystokinin_antagonist&action=info","//www.wikidata.org/wiki/Q5104300","/w/index.php?title=Special:Cite&page=Cholecystokinin_antagonist&id=545269729","/w/index.php?title=Special:Book&bookcmd=book_creator&referer=Cholecystokinin+antagonist","/w/index.php?title=Special:Book&bookcmd=render_article&arttitle=Cholecystokinin+antagonist&oldid=545269729&writer=rl","/w/index.php?title=Cholecystokinin_antagonist&printable=yes","//sr.wikipedia.org/wiki/Holecistokininski_antagonist","#","//www.wikidata.org/wiki/Q5104300#sitelinks-wikipedia","//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License","//creativecommons.org/licenses/by-sa/3.0/","//wikimediafoundation.org/wiki/Terms_of_Use","//wikimediafoundation.org/wiki/Privacy_policy","//www.wikimediafoundation.org/","//wikimediafoundation.org/wiki/Privacy_policy","/wiki/Wikipedia:About","/wiki/Wikipedia:General_disclaimer","//en.wikipedia.org/wiki/Wikipedia:Contact_us","//en.m.wikipedia.org/wiki/Cholecystokinin_antagonist","//wikimediafoundation.org/","//bits.wikimedia.org/images/wikimedia-button.png","//www.mediawiki.org/","//bits.wikimedia.org/static-1.22wmf11/skins/common/images/poweredby_mediawiki_88x31.png","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=site&only=scripts&skin=vector&*"],"instances":[],"pdf":[],"categories":["Cholecystokinin antagonists"],"headings":["References"],"image":["//en.wikipedia.org/w/index.php?title=Special:CentralAutoLogin/start&type=1x1&from=enwiki","//bits.wikimedia.org/static-1.22wmf11/skins/vector/images/search-ltr.png?303-4","//bits.wikimedia.org/images/wikimedia-button.png","//bits.wikimedia.org/static-1.22wmf11/skins/common/images/poweredby_mediawiki_88x31.png"],"tags":[],"members":[],"related":["Receptor_antagonist","Peptide","Hormone","Cholecystokinin","Cholecystokinin_receptor","Cholecystokinin_A_receptor","Cholecystokinin_B_receptor","Proglumide","Lorglumide","Devazepide","CI-988"]}